CD73 Overexpression in Podocytes: A Novel Marker of Podocyte Injury in Human Kidney Disease
Open Access
- 16 July 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (14) , 7642
Abstract
The CD73 pathway is an important anti-inflammatory mechanism in various disease settings. Observations in mouse models suggested that CD73 might have a protective role in kidney damage; however, no direct evidence of its role in human kidney disease has been described to date. Here, we hypothesized that podocyte injury in human kidney diseases alters CD73 expression that may facilitate the diagnosis of podocytopathies. We assessed the expression of CD73 and one of its functionally important targets, the C-C chemokine receptor type 2 (CCR2), in podocytes from kidney biopsies of 39 patients with podocytopathy (including focal segmental glomerulosclerosis (FSGS), minimal change disease (MCD), membranous glomerulonephritis (MGN) and amyloidosis) and a control group. Podocyte CD73 expression in each of the disease groups was significantly increased in comparison to controls (p < 0.001–p < 0.0001). Moreover, there was a marked negative correlation between CD73 and CCR2 expression, as confirmed by immunohistochemistry and immunofluorescence (Pearson r = −0.5068, p = 0.0031; Pearson r = −0.4705, p = 0.0313, respectively), thus suggesting a protective role of CD73 in kidney injury. Finally, we identify CD73 as a novel potential diagnostic marker of human podocytopathies, particularly of MCD that has been notorious for the lack of pathological features recognizable by light microscopy and immunohistochemistry.Keywords
This publication has 39 references indexed in Scilit:
- The role of purinergic pathways in the pathophysiology of gut diseases: Pharmacological modulation and potential therapeutic applicationsPharmacology & Therapeutics, 2013
- CD39 and CD73 in immunity and inflammationTrends in Molecular Medicine, 2013
- Ecto-5′-Nucleotidase (CD73) Decreases Mortality and Organ Injury in SepsisThe Journal of Immunology, 2011
- NTPDase1 Controls IL-8 Production by Human NeutrophilsThe Journal of Immunology, 2011
- Immune cell regulation by autocrine purinergic signallingNature Reviews Immunology, 2011
- Extracellular ATP in the Immune System: More Than Just a “Danger Signal”Science Signaling, 2009
- Endothelium-Derived Vasoconstriction by Purines and PyrimidinesCirculation Research, 2008
- Adenosine receptors: therapeutic aspects for inflammatory and immune diseasesNature Reviews Drug Discovery, 2008
- Unresolved issues and controversies in purinergic signallingThe Journal of Physiology, 2008
- Ecto-5’-nucleotidase: Structure function relationshipsPurinergic Signalling, 2006